Cholinesterase inhibitors have been shown to be helpful in patients with mild to moderate Alzheimer disease, but it is unclear whether treatment is still beneficial once patients have developed ...

Donepezil oral tablet is available as a brand-name drug and a generic drug. Brand name: Aricept. Donepezil comes in two oral tablet forms: tablet and disintegrating tablet (ODT). Donepezil oral tablet ...

October 8, 2010 — The acetylcholinesterase inhibitor donepezil (Aricept, Pfizer), used primarily to treat Alzheimer's disease (AD), significantly reduced the number of falls in Parkinson's disease (PD ...

Agitation is a common and distressing symptom in patients with Alzheimer's disease. Cholinesterase inhibitors improve cognitive outcomes in such patients, but the benefits of these drugs for ...

Clinical trials have shown the benefits of cholinesterase inhibitors for the treatment of mild-to-moderate Alzheimer's disease. It is not known whether treatment benefits continue after the ...

Learn everything you need to know about Donepezil-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings, ...

The acetylcholinesterase inhibitor donepezil (Aricept) failed to improve chemotherapy-related cognitive impairment (CRCI) in breast cancer survivors, a placebo-controlled trial showed. After 24 weeks ...

With the exception of the glutamate antagonist memantine, the only drug treatments currently approved by the U.S. Food and Drug Administration for treating Alzheimer disease are cholinesterase ...

The acetyl cholinesterase inhibitor donepezil is one of only four FDA-approved drugs available for treating Alzheimer disease symptoms. Soon after its initial approval for mild to moderate AD in 1996, ...

Credit: Shutterstock. Adlarity is a once-weekly transdermal formulation of donepezil that is designed to be worn for 7 days with consistent adhesion. The Food and Drug Administration (FDA) has ...

The observations that the cannabinoid 1 (CB 1) receptor antagonist/inverse agonist, rimonabant, and the selective noncompetitive inhibitor of acetylcholinesterase (AChE), donepezil, improve ...